Following on from our hugely successful first three symposiums in Manchester (2010), Sheffield (2012) and our most recent in Leeds (2014) we are pleased to announce the details of our fourth 'Synthesis in Drug Discovery and Development' Symposium.
Located in the heart of Liverpool, taking place in Liverpool Hope University in the fantastic EDEN Lecture theatre, Peakdale's Symposium aims to pull together a collection of speakers from both Industry and Academia, providing an opportunity for a section of the chemistry community to meet, network, and discuss the work our various organisations have carried out, and future opportunities. Previous industrial speakers have come from AstraZeneca, Bayer, Cancer Research UK and Pfizer amongst others.
WHO SHOULD ATTEND?
This conference is aimed at scientists and managers in pharmaceutical, agrochemical and biotechnology companies in addition to students and academics from universities and research institutions.
SPEAKERS AND DISCUSSIONS INCLUDE:
Professor David Spring - (University of Cambridge) Enriching Chemical Space to Drug Undruggable Targets
Professor Paul O'Neill - (University of Liverpool) Synthesis of Candidate Antimalarial Tetraoxanes and Chemical Biology Probes to Define the Antimalarial Mechanism of Action of the Artemisinins
Dr Adam Burrell - (Pfizer Ireland) Development of post-launch Next Generation API Processes: a Pfizer Perspective
Professor Ian Baxendale - (University of Durham) Expeditions in Flow Chemical Synthesis
Dr Matilda Bingham - (Redx Oncology Ltd) Solubility and SAR Optimisation of a Series of Novel Smoothened Inhibitors
Barrie Martin - (C4X Discovery) Synthetic Approaches to Conformationally Restricted Selective Orexin 1 Antagonists
David House - (GSK) Aromatic Amines and the AMES Test: Developing in silico Predictions
Dr Rebecca Brimage - (Peakdale Molecular Ltd) Towards new hepatitis C treatments: The Synthesis of Potent Non-Structural Protein 5A (NS5A) Inhibitors
Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences.
As a company, we have a single aim: to accelerate our customers’ discovery initiatives through innovation.
By applying our renowned skills for problem-solving, and open communications, Peakdale scientists pride themselves in seizing the initiative, providing energy, skill and creativity toward the project objectives.
Peakdale Molecular operates on two sites, from our headquarters in the Peak District and at Discovery Park located at Sandwich, Kent.
Our range of speciality services includes:
Drug Discovery Support, Nucleoside Chemistry, Materials Chemistry and Research Support.
In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.